发明名称 METHODS FOR THE TREATMENT OF CANCER USING GLIADIN PEPTIDES
摘要 Kits and methods for treating cancer comprising administration of a gliadin peptide to a patient are disclosed herein. A kit according to the invention comprises a pharmaceutical composition comprising a gliadin peptide and instructions for administering the peptide to a patient. The kit may further comprise a pharmaceutical composition comprising at least one chemotherapeutic agent such as a receptor tyrosine kinase inhibitor and instructions for co-administering the compounds. A method of treating cancer according to the invention comprises administering a gliadin peptide to a patient and may further comprise co-administering at least one chemotherapeutic agent such as a receptor tyrosine kinase inhibitor. Co-administration of a gliadin peptide and receptor tyrosine kinase inhibitor to a patient with cancer is effective to decrease or prevent resistance of the cancer to the receptor tyrosine kinase inhibitor.
申请公布号 US2016143991(A1) 申请公布日期 2016.05.26
申请号 US201615007157 申请日期 2016.01.26
申请人 BARMARSA RESEARCH LLC 发明人 Shaw Fred L.
分类号 A61K38/16;A61K31/513;A61K31/517;A61K31/5377;A61K33/24;A61K36/899 主分类号 A61K38/16
代理机构 代理人
主权项 1. A method of treating cancer comprising administering a therapeutically effective amount of a gliadin peptide to a patient with cancer, wherein the gliadin peptide comprises the amino acid sequence set forth in SEQ ID NO:1 and wherein the cancer is selected from the group consisting of non-small cell lung cancer and pancreatic cancer.
地址 Inverness IL US